Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. 2006

Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.

Cerebral amyloid angiopathy (CAA), the deposition of cerebrovascular beta-amyloid (Abeta) in the walls of arterial vessels, has been implicated in hemorrhagic stroke and is present in most cases of Alzheimer disease. Previous studies of the progression of CAA in humans and animal models have been limited to the comparison of pathological tissue from different brains at single time points. Our objective was to visualize in real time the initiation and progression of CAA in Tg2576 mice by multiphoton microscopy through cranial windows. Affected vessels were labeled by methoxy-X04, a fluorescent dye that selectively binds cerebrovascular beta-amyloid and plaques. With serial imaging sessions spaced at weekly intervals, we were able to observe the earliest appearance of CAA in leptomeningeal arteries as multifocal deposits of band-like Abeta. Over subsequent imaging sessions, we were able to identify growth of these deposits (propagation), as well as appearance of new bands (additional initiation events). Statistical modeling of the data suggested that as the extent of CAA progressed in this vascular bed, there was increased prevalence of propagation over initiation. During the early phases of CAA development, the overall pathology burden progressed at a rate of 0.35% of total available vessel area per day (95% confidence interval, 0.3-0.4%). The consistent rate of disease progression implies that this model is amenable to investigations of therapeutic interventions.

UI MeSH Term Description Entries
D007091 Image Processing, Computer-Assisted A technique of inputting two-dimensional or three-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer. Biomedical Image Processing,Computer-Assisted Image Processing,Digital Image Processing,Image Analysis, Computer-Assisted,Image Reconstruction,Medical Image Processing,Analysis, Computer-Assisted Image,Computer-Assisted Image Analysis,Computer Assisted Image Analysis,Computer Assisted Image Processing,Computer-Assisted Image Analyses,Image Analyses, Computer-Assisted,Image Analysis, Computer Assisted,Image Processing, Biomedical,Image Processing, Computer Assisted,Image Processing, Digital,Image Processing, Medical,Image Processings, Medical,Image Reconstructions,Medical Image Processings,Processing, Biomedical Image,Processing, Digital Image,Processing, Medical Image,Processings, Digital Image,Processings, Medical Image,Reconstruction, Image,Reconstructions, Image
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008578 Meninges The three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D003399 Craniotomy Surgical incision into the cranium. Craniectomy,Craniectomies,Craniotomies
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000475 Alkenes Unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. (Grant & Hackh's Chemical Dictionary, 5th ed, p408) Alkene,Olefin,Olefins,Pentene,Pentenes
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia

Related Publications

Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
July 2005, Journal of neuropathology and experimental neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
March 2001, Journal of neuropathology and experimental neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
January 2001, Advances in experimental medicine and biology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
September 2007, Brain : a journal of neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
November 2012, Journal of neuropathology and experimental neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
June 2002, Annals of neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
October 2009, Alzheimer's research & therapy,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
January 2020, Nature reviews. Neurology,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
January 2016, Frontiers in aging neuroscience,
Elissa M Robbins, and Rebecca A Betensky, and Sarah B Domnitz, and Susan M Purcell, and Monica Garcia-Alloza, and Charles Greenberg, and G William Rebeck, and Bradley T Hyman, and Steven M Greenberg, and Matthew P Frosch, and Brian J Bacskai
January 2015, Journal of stroke,
Copied contents to your clipboard!